/Investor DB

Mérieux Equity Partners — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

Health in Codehealthincode.comin𝕏Feb 2026

Health in Code is a genetic diagnostics laboratory that performs full genetic studies, variant interpretation, and clinical-genetic reporting, and develops and manufactures disease diagnostic kits for specialized labs.

BiotechDigital HealthMedical Devices

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.